Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 79 | +6 |
| Shares | 18.6M | 1.13M | 14.9M | −2.62M (−15.0%) |
| Value | $135.9M | $8.23M | $21.6M | −$106.1M (−83.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,085,439 | $1.57M | 0.00% |
| Qube Research & Technologies Ltd | 322,186 | $467.2K | 0.00% |
| XTX Topco Ltd | 231,148 | $335.2K | 0.02% |
| ExodusPoint Capital Management, LP | 186,132 | $270.0K | 0.00% |
| Squarepoint Ops LLC | 86,039 | $124.8K | 0.00% |
| Goldman Sachs Group Inc | 80,556 | $116.8K | 0.00% |
| Verition Fund Management LLC | 61,640 | $89.4K | 0.00% |
| HRT Financial LP | 48,483 | $70.0K | 0.00% |
| Sanctuary Advisors, LLC | 60,000 | $59.7K | 0.00% |
| Two Sigma Securities, LLC | 35,980 | $52.2K | 0.00% |
| Sherbrooke Park Advisers LLC | 24,865 | $36.1K | 0.01% |
| Millennium Management LLC | 20,030 | $29.0K | 0.00% |
| Engineers Gate Manager LP | 16,617 | $24.1K | 0.00% |
| SG Americas Securities, LLC | 14,372 | $21.0K | 0.00% |
| FinTrust Capital Advisors, LLC | 10,000 | $14.5K | 0.00% |
| Capital Analysts, LLC | 6,300 | $9.00K | 0.00% |
| Simplex Trading, LLC | 2,431 | $3.00K | 0.00% |
| Coastline Trust Co | 200 | $290 | 0.00% |
| Jones Financial Companies LLLP | 73 | $123 | 0.00% |
| Sterling Capital Management LLC | 19 | $28 | 0.00% |
Sold out (14)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Avoro Capital Advisors LLC | 3,999,999 | $29.2M |
| Invesco Ltd. | 423,520 | $3.09M |
| Kornitzer Capital Management Inc | 74,251 | $541.3K |
| EAM Investors, LLC | 70,586 | $514.6K |
| Citadel Advisors LLC | 22,784 | $166.1K |
| MetLife Investment Management | 11,892 | $86.7K |
| Quest Partners LLC | 6,926 | $50.5K |
| Cetera Trust Company, N.A | 1,000 | $7.29K |
| Parallel Advisors, LLC | 176 | $1.28K |
| Comerica Bank | 158 | $1.15K |
| Quadrant Capital Group LLC | 110 | $802 |
| Macquarie Group Ltd | 88 | $642 |
| GAMMA Investing LLC | 38 | $277 |
| Farther Finance Advisors, LLC | 31 | $246 |
Not filed for Q3 2024 yet (1)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,129,143 | $8.23M |